Mad in America
JANUARY 25, 2024
The study, titled “Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey,” delves into the challenging decisions faced by individuals considering SSRI and SNRI antidepressants, which are common treatments for depression. Only a third of patients are satisfied with these medications.
Mad in America
DECEMBER 11, 2023
Take, for instance, a recent meta-analysis finding that exercise is just as good as antidepressants at treating mild to moderate depression —and that adding drugs to the regimen does not improve outcomes. Most people still receive a pill if they present with mild depression—or even undiagnosable, vague malaise.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
APRIL 27, 2024
This was a story of a great medical advance, and the announced results from the STAR*D trial, heralded by the NIMH as the “largest and longest study ever done to evaluate depression treatment,” fit into that story of medical progress, for it told of 70% of depressed patients becoming “symptom free” after repeated treatments with antidepressants.
Mad in America
DECEMBER 31, 2024
The findings reinforce the view that addressing the high prevalence rates of depression via symptom recognition and treatment with antidepressants is unlikely to be effective. The absolute long-term efficacy of antidepressants in real-world settings is disappointingly modest.
Mad in America
JANUARY 4, 2025
American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct. Such was the news that TheNew York Times found fit to print.
Lightwork
FEBRUARY 20, 2025
Mindfulness and Relaxation Techniques Mindfulness practices offer powerful tools to manage SAD symptoms by helping you stay grounded in the present moment. The right SAD lamp, positioned correctly at your desk or breakfast table, can significantly impact your daily mood and energy levels.
Bullet Psych
OCTOBER 7, 2022
Patients may hide symptoms or present somatic complaints. Pharmacotherapy : Fluoxetine is the only FDA approved medication for the treatment of bulimia nervosa (in adults) and should be considered as the first-line medication option. The effective dose is typically higher than average depression treatment (60-80 mg/day).
Expert insights. Personalized for you.
142 
Let's personalize your content